Financial Wire

HUB24 Total Funds Under Administration Jump 22% in Fiscal Q3; Shares Down 4%

-- HUB24 (ASX:HUB) said its total funds under administration clocked in at AU$151.74 billion as of March 31, up 22% from the AU$124.13 billion a year earlier, according to a Tuesday Australian bourse filing.

Platform net inflows during the fiscal third quarter were AU$3.98 billion, rising 9% from the same period in the previous year, when excluding large migrations.

Platform funds under administration clocked in at AU$127.83 billion, jumping 25% from AU$102.51 billion in the prior-year period.

The company said 37 new licensee agreements were signed during the quarter, and the total number of advisers using the platform increased by 272 to 5,549.

HUB24's shares plunged almost 4% in recent Tuesday trade.

Related Articles

Asia

Wasion to Raise HK$1.5 Billion via Share Placement, Top-Up Subscription

Wasion Holdings (HKG:3393) plans to raise about HK$1.47 billion in net proceeds through a share placing and top-up subscription, according to a Tuesday Hong Kong bourse filing.Shareholder Star Treasure Investments will place up to 50 million shares at HK$30.00 each to at least six investors on a best-efforts basis.The placing represents about 5% of the company's existing issued share capital.Wasion will issue the same number of new shares to the seller under a top-up subscription at the same price.Net proceeds will be used for business expansion, research and development, overseas market growth, potential acquisitions, debt repayment, and general working capital.

$HKG:3393
Asia

Recce Pharmaceuticals Says Indonesian Regulator Completes Routine Regulatory Inspection of Phase Three Clinical Trial Site

Recce Pharmaceuticals (ASX:RCE) said the Indonesian National Agency of Drug and Food Control completed a comprehensive routine regulatory inspection of a phase three clinical trial site in Indonesia, with no findings noted that prevent the study from continuing, according to a Tuesday Australian bourse filing.The phase three clinical trial for the treatment of diabetic foot infections is advancing patient dosing, and it is on track to produce interim data from 155 patients.The firm's shares rose 2% in recent trading on Tuesday.

$ASX:RCE
Asia

ASX Midday Sector Update: Consumer Staples Gain, Energy Stocks Slide

Consumer staples stocks were advancing about 0.5% in midday trading Tuesday, posting a very thin lead over gains for information technology shares.Woolworths Group (ASX:WOW) was up nearly 1% and Coles Group (ASX:COL) rose less than 1%.On the flip side, energy stocks were down 1% as oil prices trended lower amid hopes that Iran will join a second round of peace negotiations with the US.Woodside Energy Group (ASX:WDS) was shedding almost 2%, while Santos (ASX:STO) was down more than 1%.

$^AXJO$ASX:COL$ASX:STO$ASX:WDS$ASX:WOW